Losartan Potassium and Hydrochlorothiazide

Product NDC
70518-3409
11-digit product format
705183409
Labeler code
70518
Product ID
70518-3409_eff7033f-8caa-6a98-e053-2995a90a9510
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
losartan potassium and hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA201845
Marketing category
ANDA
Marketing start
2022-04-11
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Active strength
13 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE
3ST302B24ALOSARTAN POTASSIUM124750-99-8LOSARTAN POTASSIUM

Packages

Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-3409-07051834090090 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-3409-0) 2022-04-110000-00-00NoNoCurrent